Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
| Fund | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| K-GHEALTH | +9.43% | +3.16% | +4.24% | +10.47% | +8.19% | +16.50% | +16.26% | +23.39% | −1.02% | +46.67% | +98.72% | +52.44% |
| UOBSHC | +7.32% | +2.11% | +2.17% | +8.52% | +8.02% | +13.59% | +15.82% | +16.67% | −9.98% | +24.80% | +54.93% | +30.64% |
| ES-HEALTHCARERMF | +9.13% | +2.32% | +2.44% | +7.06% | +4.90% | +13.62% | +18.85% | +37.57% | +13.09% | +60.83% | +112.09% | +59.63% |
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
| K-GHEALTH | ES-HEALTHCARERMF | |
|---|---|---|
| Held by both | ||
 Eli Lilly and Co | 8.17% | 9.38% |
 Johnson & Johnson | 6.43% | 7.59% |
 ABBVIE | 7.45% | 4.81% |
 AstraZeneca | 4.19% | 3.62% |
 Unitedhealth Group | 3.37% | 4.17% |
 Thermo Fisher | 4.70% | 3.27% |
 Novartis | 4.59% | 2.67% |
 Merck & | 5.41% | 2.29% |
| Only in K-GHEALTH | ||
 Abbott Laboratories | 2.96% | N/A |
 Danaher | 2.96% | N/A |
| Only in ES-HEALTHCARERMF | ||
 Roche | N/A | 2.62% |
 argenx | N/A | 2.39% |
30 Dec 2025 → 3 Nov 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| K-GHEALTH | +9.43% | 15.47% | 0.61 |
| ES-HEALTHCARERMF | +9.13% | 16.65% | 0.55 |
| UOBSHC | +7.32% | 15.38% | 0.48 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | K-GHEALTH | UOBSHC | ES-HEALTHCARERMF |
|---|---|---|---|
Fund details | |||
| Fund size | 3,130 million | 1,258 million | 356 million |
| Inception date | 26 Nov 2014 | 9 Sep 2014 | 7 Jul 2015 |
| Master fund | JPMorgan Funds – Global Healthcare Fund, Class A (acc) - USD | United Global Healthcare Fund | กองทุน Janus Henderson Global Life Sciences Fund |
| Dividend policy | Pays | Does not pay | Does not pay |
Risk and currency hedging | |||
| Risk level | 6 | 7 | 7 |
| Hedging policy | Hedged at the manager's discretion | Hedged at the manager's discretion | Hedged at the manager's discretion |
| Share hedged | 93.16% | 97.39% | 96.33% |
Minimum purchase and redemption | |||
| First purchase | 500 THB | 0.01 THB | 1 THB |
| Subsequent purchase | 500 THB | 0.01 THB | 1 THB |
| Redemption (amount) | 500 THB | 0.01 THB | 1 THB |
| Redemption (units) | No minimum | No minimum | 1 units |
| Balance (amount) | 50 THB | No minimum | No minimum |
| Balance (units) | No minimum | No minimum | No minimum |
Order cut-off and redemption payment | |||
| Buy before | 15:30 | 15:30 | 15:30 |
| Redeem before | 14:30 | 14:00 | 15:30 |
| Redemption paid | T+4 | T+5 | T+4 |
